Industries > Pharma > Global Pharmacovigilance Market Forecast 2018-2028

Global Pharmacovigilance Market Forecast 2018-2028

US, Japan, Germany, the UK, France, Italy, Spain, Brazil, Russia, India, China, South Korea, National Pharmacovigilance Systems, Leading Companies, Trends

PUBLISHED: 21 December 2017
PAGES: 150
PRODUCT CODE: PHA0272
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0272 Categories: ,

The global pharmacovigilance market is expected to grow at a CAGR of 4.8% in the first half of the forecast period. The pharmacovigilance market is estimated to reach $ 11.5bn in 2023.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 150-page report you will receive 47 tables and 61 figures– all unavailable elsewhere. 

The 150-page report provides clear detailed insight into the global pharmacovigilance market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical R&D Spending forecasts from 2017-2028

• Global Pharmacovigilance market forecasts from 2017-2028

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– Japan
– EU: Germany, France, the UK, Italy, Spain, Others
– BRIC: Brazil, Russia, India, China 
– South Korea
– Others

Global Pharmacovigilance Market Forecast 2018-2028

• This report provides a SWOT and STEP Analysis of the pharmacovigilance market. This report also discusses the Drivers and Restraints of the pharmacovigilance market.

• Our study discusses the selected leading companies that are the major players in the pharmacovigilance market:
– Accenture PLC
– Cognizant Technology Solutions Corporation
– Tata Consultancy Services (TCS)
– Capgemini SE
– Tech Mahindra Limited
– Infosys Limited (Infosys)
– Wipro Limited (Wipro)
– Oracle Corporation (Oracle)
– Bristol-Myers Squibb Company 
– HCL Technologies Ltd.
– Olympus Corporation

• Moreover, this report discusses the following:
– Reporting systems for adverse drug reactions (ADRs) – their present and future, including data on reported and recorded events by year and region
– Safety monitoring using reporting from social media 
– Improvements in data collection and communication leading to more-flexible drug approval processes – changing routes of marketing authorization
– Policies of national and international bodies, and regulators’ roles in present and future pharmacovigilance plans
– Collaboration between the FDA and EMA, and application of pharmacogenomics and biomarkers
– Use of electronic health record (EHR) systems – a live model for drug safety, applying information systems.

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharmacovigilance market. You find data, trends and predictions. 

Buy our report today Global Pharmacovigilance Market Forecast 2018-2028: US, Japan, Germany, the UK, France, Italy, Spain, Brazil, Russia, India, China, South Korea, National Pharmacovigilance Systems, Leading Companies, Trends.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

Download sample pages

Complete the form below to download your free sample pages for Global Pharmacovigilance Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Pharmacovigilance Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

READ

Visiongain Publishes Next Generation Sequencing Market Report 2021-2031

Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.

04 June 2021

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2021-2031

The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.

04 June 2021

READ

Visiongain Publishes Anti-infective Agents Market Report 2021-2031

Rising incidences of infectious diseases is one of the prime factors driving the growth of the global anti-infective agents market globally.

27 May 2021

READ

Categories